Phase II Trial of Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With Cholangiocarcinoma

NCT02181634 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
74
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

PrECOG, LLC.

Collaborators